Loading ...

Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

adamantane-conjugated poly(acrylic acid)/β-cyclodextrin-conjugated poly(acrylic acid)/adamantane-terminated polyethylene glycol supramolecular nanoparticles

Based on

1 Articles
2017 Most recent source

Composition

1

adamantane-conjugated poly(acrylic acid)/β-cyclodextrin-conjugated poly(acrylic acid)

AD-conjugated PAA/β-CD-conjugated PAA
Type Complex Compound
Formula
Role core
2

adamantane-terminated poly(ethylene glycol)

adamantane-terminated poly(ethylene oxide) adamantane-terminated polyethylene glycol adamantane-terminated polyethylene oxide adamantane-terminated polyoxyethylene AD-terminated PEG
Type Polymer
Formula
Role layer

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
Zeta potential

More information available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
drug delivery

More information available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
infrared spectroscopy

More information/entries available to subscribers only.

Or, view sample content

Biological effects

Biological system Test details Nanomaterial Variant Source
HeLa cells

More information available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Physical formation
Source:
Product

adamantane-conjugated poly(acrylic acid)/β-cyclodextrin-conjugated poly(acrylic acid)/adamantane-terminated polyethylene glycol supramolecular nanoparticles

Size: not specified

Medium: water

Support: none

Method 2

Type: Physical formation
Source:
Starting materials
  • adamantane-terminated poly(ethylene glycol)
  1. vuE3jTe5GwhCho
Product

adamantane-conjugated poly(acrylic acid)/β-cyclodextrin-conjugated poly(acrylic acid)/adamantane-terminated polyethylene glycol supramolecular nanoparticles

Size: ~ 50 nm

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial